Published in Hum Gene Ther on April 01, 2013
Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications. Hum Gene Ther (2013) 0.85
The road ahead: working towards effective clinical translation of myocardial gene therapies. Ther Deliv (2014) 0.81
Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction. Gene Ther (2015) 0.75
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol (2011) 9.68
Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol (2004) 5.71
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci (1995) 4.83
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med (2001) 4.02
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther (2002) 2.86
Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand (2003) 2.75
In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci U S A (1990) 2.21
Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. Biochim Biophys Acta (2005) 2.20
Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation (2008) 2.17
Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med (2009) 2.12
Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation (2003) 2.03
Intracellular trafficking of adeno-associated viral vectors. Gene Ther (2005) 1.95
Direct visualization at the single-cell level of electrically mediated gene delivery. Proc Natl Acad Sci U S A (2002) 1.90
Intracellular trafficking of nonviral vectors. Gene Ther (2005) 1.78
Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation (1990) 1.72
High-velocity microprojectiles for delivering nucleic acids into living cells. 1987. Biotechnology (1992) 1.69
Nonviral gene delivery: principle, limitations, and recent progress. AAPS J (2009) 1.69
Cell-penetrating peptides: breaking through to the other side. Trends Mol Med (2012) 1.68
The magnetofection method: using magnetic force to enhance gene delivery. Biol Chem (2003) 1.66
Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy. Circ Res (2007) 1.59
Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther (2004) 1.55
Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Adv Drug Deliv Rev (2005) 1.49
Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther (2002) 1.49
Adenovirus type 5 interactions with human blood cells may compromise systemic delivery. Mol Ther (2006) 1.47
Gene therapy for heart failure. Circ Res (2012) 1.46
Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation (1994) 1.45
Intracellular transport of recombinant adeno-associated virus vectors. Gene Ther (2012) 1.44
Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure. Expert Opin Biol Ther (2010) 1.41
Intracellular routing of plasmid DNA during non-viral gene transfer. Adv Drug Deliv Rev (2005) 1.35
Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. Mol Ther (2002) 1.34
Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol (2007) 1.29
Ultrarapid, highly efficient viral gene transfer to the heart. Proc Natl Acad Sci U S A (1997) 1.27
Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun (2005) 1.26
The many ways to cross the plasma membrane. Proc Natl Acad Sci U S A (2001) 1.26
Targeted high-efficiency, homogeneous myocardial gene transfer. J Mol Cell Cardiol (2007) 1.26
Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway. Am J Physiol (1997) 1.24
Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther (2007) 1.23
Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc Res (2006) 1.22
Endothelial cell barrier enhancement by ATP is mediated by the small GTPase Rac and cortactin. Am J Physiol Lung Cell Mol Physiol (2006) 1.22
Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo. Gene Ther (2011) 1.21
How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures? Hum Gene Ther (2001) 1.21
Magnetofection potentiates gene delivery to cultured endothelial cells. J Vasc Res (2003) 1.20
Gene transfer by electroporation. Mol Biotechnol (1997) 1.19
Electroporation-mediated gene transfer in cardiac tissue. FEBS Lett (1998) 1.17
Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Ther (2000) 1.17
Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer. Circulation (2002) 1.14
Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction. Circulation (2011) 1.14
Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther (1999) 1.12
Exosomes as nano-theranostic delivery platforms for gene therapy. Adv Drug Deliv Rev (2012) 1.10
Lack of adenosine causes myocardial refractoriness. J Am Coll Cardiol (1998) 1.09
Global cardiac-specific transgene expression using cardiopulmonary bypass with cardiac isolation. Ann Thorac Surg (2002) 1.09
Physical methods of nucleic acid transfer: general concepts and applications. Br J Pharmacol (2009) 1.09
Femtosecond infrared laser-an efficient and safe in vivo gene delivery system for prolonged expression. Mol Ther (2003) 1.08
Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart: application to study of phospholamban physiology. Circulation (2003) 1.08
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. Am J Physiol Heart Circ Physiol (2005) 1.04
Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin. Gene Ther (1998) 1.04
Multifunctional magnetic nanoparticles for targeted delivery. Nanomedicine (2009) 1.03
Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery. J Am Coll Cardiol (2004) 1.03
Gene gun and other non-viral approaches for cancer gene therapy. Nat Med (1995) 1.02
Mechanisms of alpha-thrombin, histamine, and bradykinin induced endothelial permeability. J Cell Physiol (1996) 1.01
Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. Mol Ther (2002) 1.00
In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo. Gene Ther (2001) 1.00
Endothelium-targeted gene and cell-based therapies for cardiovascular disease. Arterioscler Thromb Vasc Biol (2004) 0.99
Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J Gene Med (2000) 0.99
Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression. Gene Ther (2009) 0.99
Highly efficient adenovirus-mediated gene transfer to cardiac myocytes after single-pass coronary delivery. Hum Gene Ther (2000) 0.99
Laser-based gene transfection and gene therapy. IEEE Trans Nanobioscience (2008) 0.98
Electroporation-mediated gene transfer directly to the swine heart. Gene Ther (2012) 0.97
Use of minicircle plasmids for gene therapy. Methods Mol Biol (2009) 0.97
Enhanced thoracic gene delivery by magnetic nanobead-mediated vector. J Gene Med (2008) 0.96
Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction. J Am Coll Cardiol (2004) 0.96
Phosphodiesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium. J Mol Cell Cardiol (2001) 0.96
Ultrasound-mediated microbubble destruction enhances VEGF gene delivery to the infarcted myocardium in rats. Clin Imaging (2004) 0.95
Current strategies for myocardial gene delivery. J Mol Cell Cardiol (2010) 0.95
Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. Mol Ther (2003) 0.94
Gene therapy for ischemic heart disease. Expert Opin Biol Ther (2011) 0.94
Efficient viral gene transfer to rodent hearts in vivo. Methods Mol Biol (2003) 0.94
Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide. Gene Ther (2008) 0.92
The evolution of heart gene delivery vectors. J Gene Med (2011) 0.92
The laser method for efficient introduction of foreign DNA into cultured cells. Exp Cell Res (1986) 0.91
Differing effects of histamine and serotonin on microvascular permeability in anaesthetized rats. J Physiol (1997) 0.91
In vivo electroporation mediated gene delivery to the beating heart. PLoS One (2010) 0.90
Targeted gene therapy for the treatment of heart failure. Can J Cardiol (2011) 0.89
Gene transfer: how can the biological barriers be overcome? J Membr Biol (2010) 0.89
Gene delivery technologies for cardiac applications. Gene Ther (2012) 0.87
Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban. Am J Physiol Heart Circ Physiol (2008) 0.87
Gene therapy approaches for cardiovascular diseases. Curr Gene Ther (2004) 0.87
A minimally invasive approach for efficient gene delivery to rodent hearts. Gene Ther (2004) 0.87
Prospects for gene transfer for clinical heart failure. Gene Ther (2012) 0.87
Cytochemical demonstration of sites of hydrogen peroxide generation and increased vascular permeability in isolated pig hearts after ischaemia and reperfusion. Microsc Res Tech (1998) 0.86
Emerging vectors and targeting methods for nonviral gene therapy. Expert Opin Emerg Drugs (2006) 0.86
Widespread regional myocardial transfection by plasmid encoding Del-1 following retrograde coronary venous delivery. Catheter Cardiovasc Interv (2003) 0.86
Electroporation for gene transfer to skeletal muscles: current status. BioDrugs (2004) 0.85
Gene printer: laser-scanning targeted transfection of cultured cardiac neonatal rat cells. Cell Commun Adhes (2006) 0.85
Application of magnetic nanoparticles to gene delivery. Int J Mol Sci (2011) 0.85
Low-volume jet injection for intradermal immunization in rabbits. BMC Biotechnol (2002) 0.82
Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets. Proc Natl Acad Sci U S A (2007) 0.82
Adeno-associated virus vector delivery to the heart. Methods Mol Biol (2011) 0.82
Nonviral gene gun mediated transfer into the beating heart. ASAIO J (2003) 0.81
Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization. J Thorac Cardiovasc Surg (1998) 0.81
Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg (2007) 5.32
Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation (2006) 3.38
The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg (2009) 3.24
Myosin gene mutation correlates with anatomical changes in the human lineage. Nature (2004) 2.69
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2011) 2.69
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67
Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation (2006) 2.51
2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2012) 2.40
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2011) 2.24
Guidelines for reporting data and outcomes for the surgical treatment of atrial fibrillation. Ann Thorac Surg (2007) 1.91
Cardiac surgery in Jehovah's Witness patients: ten-year experience. Ann Thorac Surg (2011) 1.85
The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration. Ann Thorac Surg (2006) 1.54
From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol (2003) 1.47
Surgical management of endocarditis: the society of thoracic surgeons clinical practice guideline. Ann Thorac Surg (2011) 1.36
Uniform scale-independent gene transfer to striated muscle after transvenular extravasation of vector. Circulation (2005) 1.30
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol (2008) 1.21
Management of alveolar air leaks after pulmonary resection. Ann Thorac Surg (2010) 1.16
2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg (2012) 1.15
Sheep (Ovis aries) as a model for cardiovascular surgery and management before, during, and after cardiopulmonary bypass. J Am Assoc Lab Anim Sci (2015) 1.07
Gender-specific practice guidelines for coronary artery bypass surgery: perioperative management. Ann Thorac Surg (2005) 1.06
Relationship between race and mortality and morbidity after valve replacement surgery. Circulation (2005) 0.97
The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg (2005) 0.96
AAV6-βARKct gene delivery mediated by molecular cardiac surgery with recirculating delivery (MCARD) in sheep results in robust gene expression and increased adrenergic reserve. J Thorac Cardiovasc Surg (2011) 0.95
Current strategies for myocardial gene delivery. J Mol Cell Cardiol (2010) 0.95
Cardiac surgical delivery of the sarcoplasmic reticulum calcium ATPase rescues myocytes in ischemic heart failure. Ann Thorac Surg (2013) 0.91
A translatable, closed recirculation system for AAV6 vector-mediated myocardial gene delivery in the large animal. Methods Mol Biol (2011) 0.90
Cardiac gene therapy: optimization of gene delivery techniques in vivo. Hum Gene Ther (2010) 0.89
Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis species: case report and review of the literature. J Thorac Cardiovasc Surg (2006) 0.89
Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications. Hum Gene Ther (2013) 0.85
Swallow syncope after cardiac surgery in a sheep. Vet Surg (2013) 0.85
Model-specific selection of molecular targets for heart failure gene therapy. J Gene Med (2011) 0.83
Gene transfer to muscle from the isolated regional circulation. Methods Mol Biol (2011) 0.82
The road ahead: working towards effective clinical translation of myocardial gene therapies. Ther Deliv (2014) 0.81
MCARD-mediated gene transfer of GRK2 inhibitor in ovine model of acute myocardial infarction. J Cardiovasc Transl Res (2012) 0.81
Aprotinin in cardiac surgery. N Engl J Med (2006) 0.81
Gene therapy during cardiac surgery: role of surgical technique to minimize collateral organ gene expression. Interact Cardiovasc Thorac Surg (2010) 0.80
A needleless liquid jet injection delivery method for cardiac gene therapy: a comparative evaluation versus standard routes of delivery reveals enhanced therapeutic retention and cardiac specific gene expression. J Cardiovasc Transl Res (2014) 0.80
Homograft aortic root replacement during pregnancy. Ann Thorac Surg (2002) 0.80
Special Articles: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Anesth Analg (2011) 0.79
A pharmacokinetic analysis of molecular cardiac surgery with recirculation mediated delivery of βARKct gene therapy: developing a quantitative definition of the therapeutic window. J Card Fail (2011) 0.78
Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection. J Transl Med (2014) 0.77
Valid comparisons of antifibrinolytic agents used in cardiac surgery. Circulation (2007) 0.77
Resection of a large atrial hemangioma using a bloodless surgical technique: a case report. Heart Surg Forum (2007) 0.76
Surgical methods for cardiac gene transfer. Future Cardiol (2014) 0.75
MiRNAs as potential molecular targets in heart failure. Future Cardiol (2014) 0.75
Reoperative cardiac surgery in Jehovah's witness patients with patent internal thoracic artery grafts: how far can we push the envelope? Heart Surg Forum (2008) 0.75
Should a Jehovah's Witness patient who faces imminent exsanguination be transfused? Ann Thorac Surg (2011) 0.75
Minimally invasive cardiac surgery using a flexible aortic clamp. Heart Surg Forum (2007) 0.75
Bicuspidization of the tricuspid valve for the treatment of posterior leaflet endocarditis: a case report. Heart Surg Forum (2007) 0.75
Cardiovascular function in normotensive offspring of persons with essential hypertension and black race. J Clin Hypertens (Greenwich) (2007) 0.75